TD Asset Management Inc

Position in DYN — Dyne Therapeutics, Inc.

CIK 1056053 Toronto, A6

Position in DYN

as of Jun 30, 2026 · filed Aug 4, 2026 Compact

Position Value

$12,173,567

+$2,577,141 QoQ

Shares Held

548,112

+3.6% QoQ

Ownership

0.294%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#50

of 245 holders

Holding Since

Sep 2020

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

TD Asset Management Inc holds $1,129,937,988 across 119 Biotechnology names. DYN ranks #22 (1.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	259,317	$161,694,522
2	VRTX	Vertex Pharmaceuticals Inc / Ma	207,960	$103,299,970
3	HALO	Halozyme Therapeutics, Inc.	1,115,730	$87,328,187
4	ALNY	Alnylam Pharmaceuticals, Inc.	233,696	$70,349,506
5	CYTK	Cytokinetics Inc	385,130	$32,809,224
6	RPRX	Royalty Pharma plc	567,497	$31,819,556
7	ASND	Ascendis Pharma A/S	119,085	$31,762,351
8	KYMR	Kymera Therapeutics, Inc.	272,900	$31,293,443

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$12,173,567	548,112	+3.6%	Shares	Sole	2026-08-04
2026-03-31	$9,596,426	529,312	+26.1%	Shares	Sole	2026-05-11
2025-12-31	$8,210,427	419,756	+1959.4%	Shares	Sole	2026-02-10
2025-09-30	$257,832	20,382	-5.9%	Shares	Sole	2025-11-10
2025-03-31	$226,521	21,656	-69.9%	Shares	Sole	2025-05-07
2024-12-31	$1,697,026	72,030	-33.8%	Shares	Sole	2025-02-11
2024-09-30	$3,909,173	108,830	-28.5%	Shares	Sole	2024-11-01
2024-06-30	$5,371,490	152,210	+103.5%	Shares	Sole	2024-08-02
2024-03-31	$2,123,572	74,800	+225.2%	Shares	Sole	2024-05-08
2023-09-30	$206,080	23,000	+10.0%	Shares	Sole	2023-10-27
2023-03-31	$240,768	20,900	-24.2%	Shares	Sole	2023-05-10
2020-12-31	$579,306	27,586	0.0%	Shares	Sole	2021-02-16
2020-09-30	$556,961	27,586	—	Shares	Sole	2020-11-10
No filing history on record for this holder in this stock.